| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | COVER ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
||||||||
|
||||||||||
Dr. Saslow is Director, Breast and Gynecologic Cancer, American Cancer Society, Atlanta, GA.
Dr. Runowicz is Vice Chairman, Department of Obstetrics and Gynecology, St. Lukes-Roosevelt Hospital Center, New York, NY.
Dr. Solomon is Project Officer, ASCUS/LSIL Triage Study, National Cancer Institute, Rockville, MD.
Dr. Moscicki is Director, Teen Colposcopy Clinic and Associate Director, Division of Adolescent Medicine, University of California, San Francisco, CA.
Dr. Smith is Director of Cancer Screening, American Cancer Society, Atlanta, GA.
Dr. Eyre is Chief Medical Officer and Executive Vice President for Research and Cancer Control, American Cancer Society, Atlanta, GA, and Editor in Chief of CA.
Dr. Cohen is Professor and Director, Division of Gynecologic Oncology, and Vice Chairman, Department of Obstetrics, Gynecology, and Reproductive Science, The Mount Sinai Medical Center, New York, NY.
An update to the American Cancer Society (ACS) guideline regarding screening for the early detection of cervical neoplasia and cancer, based on recommendations from a formal review and recent workshop, is presented. The new screening recommendations address when to begin screening, when screening may be discontinued, whether to screen women who have had a hysterectomy, appropriate screening intervals, and new screening technologies, including liquid-based cytology and HPV DNA testing.
This article has been cited by other articles:
|
|
 |
|
  S F Derchain, L O Sarian, P Naud, C Roteli-Martins, A Longatto-Filho, S Tatti, M Branca, M Erzen, L Serpa-Hammes, J Matos, et al. Safety of screening with Human papillomavirus testing for cervical cancer at three-year intervals in a high-risk population: experience from the LAMS study J Med Screen, June 1, 2008; 15(2): 97 - 104. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Smith, V. Cokkinides, and O. W. Brawley Cancer Screening in the United States, 2008: A Review of Current American Cancer Society Guidelines and Cancer Screening Issues CA Cancer J Clin, May 1, 2008; 58(3): 161 - 179. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. E. Castle, J. T. Cox, J. Jeronimo, D. Solomon, C. M. Wheeler, P. E. Gravitt, and M. Schiffman An Analysis of High-Risk Human Papillomavirus DNA-Negative Cervical Precancers in the ASCUS-LSIL Triage Study (ALTS) Obstet. Gynecol., April 1, 2008; 111(4): 847 - 856. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. D. Datta, L. A. Koutsky, S. Ratelle, E. R. Unger, J. Shlay, T. McClain, B. Weaver, P. Kerndt, J. Zenilman, M. Hagensee, et al. Human Papillomavirus Infection and Cervical Cytology in Women Screened for Cervical Cancer in the United States, 2003-2005 Ann Intern Med, April 1, 2008; 148(7): 493 - 500. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. F. Sawaya Adding Human Papillomavirus Testing to Cytology for Primary Cervical Cancer Screening: Shooting First and Asking Questions Later Ann Intern Med, April 1, 2008; 148(7): 557 - 559. [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Goldhaber-Fiebert, N. K. Stout, J. A. Salomon, K. M. Kuntz, and S. J. Goldie Cost-Effectiveness of Cervical Cancer Screening With Human Papillomavirus DNA Testing and HPV-16,18 Vaccination J Natl Cancer Inst, March 5, 2008; 100(5): 308 - 320. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Herbert and J. Coffin Reducing Patient Risk for Human Papillomavirus Infection and Cervical Cancer J Am Osteopath Assoc, February 1, 2008; 108(2): 65 - 70. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Ogunmodede, S. H. Yale, B. Krawisz, G. C. Tyler, and A. C. Evans Human Papillomavirus Infections in Primary Care Clin. Med. Res., December 1, 2007; 5(4): 210 - 217. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. F. Sawaya and H. C. Sox Trials That Matter: Liquid-Based Cervical Cytology: Disadvantages Seem to Outweigh Advantages Ann Intern Med, November 6, 2007; 147(9): 668 - 669. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Hildesheim, R. Herrero, S. Wacholder, A. C. Rodriguez, D. Solomon, M. C. Bratti, J. T. Schiller, P. Gonzalez, G. Dubin, C. Porras, et al. Effect of Human Papillomavirus 16/18 L1 Viruslike Particle Vaccine Among Young Women With Preexisting Infection: A Randomized Trial JAMA, August 15, 2007; 298(7): 743 - 753. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Edelman, J. Anderson, S. Lai, D. A.V. Braner, and K. Tegtmeyer Pelvic Examination N. Engl. J. Med., June 28, 2007; 356(26): e26 - e26. [PDF]
|
|
|
|
|
|
R. A. Smith, V. Cokkinides, and H. J. Eyre Cancer Screening in the United States, 2007: A Review of Current Guidelines, Practices, and Prospects CA Cancer J Clin, March 1, 2007; 57(2): 90 - 104. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Solomon, N. Breen, and T. McNeel Cervical Cancer Screening Rates in the United States and the Potential Impact of Implementation of Screening Guidelines CA Cancer J Clin, March 1, 2007; 57(2): 105 - 111. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Tiro, H. I. Meissner, S. Kobrin, and V. Chollette What Do Women in the U.S. Know about Human Papillomavirus and Cervical Cancer? Cancer Epidemiol. Biomarkers Prev., February 1, 2007; 16(2): 288 - 294. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. B. Knudsen, P. M. McMahon, and G. S. Gazelle Use of Modeling to Evaluate the Cost-Effectiveness of Cancer Screening Programs J. Clin. Oncol., January 10, 2007; 25(2): 203 - 208. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Saslow, P. E. Castle, J. T. Cox, D. D. Davey, M. H. Einstein, D. G. Ferris, S. J. Goldie, D. M. Harper, W. Kinney, A.-B. Moscicki, et al. American Cancer Society Guideline for Human Papillomavirus (HPV) Vaccine Use to Prevent Cervical Cancer and Its Precursors CA Cancer J Clin, January 1, 2007; 57(1): 7 - 28. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Aklimunnessa, M. Mori, M. M. H. Khan, F. Sakauchi, T. Kubo, Y. Fujino, S. Suzuki, S. Tokudome, A. Tamakoshi, and for the JACC Study Group Effectiveness of Cervical Cancer Screening Over Cervical Cancer Mortality Among Japanese Women Jpn. J. Clin. Oncol., August 1, 2006; 36(8): 511 - 518. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Irwin, D. Montano, D. Kasprzyk, L. Carlin, C. Freeman, R. Barnes, N. Jain, J. Christian, and C. Wolters Cervical Cancer Screening, Abnormal Cytology Management, and Counseling Practices in the United States Obstet. Gynecol., August 1, 2006; 108(2): 397 - 409. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-H. Feng, X. Li, L. Wang, L. Zhou, and G. I. Gorodeski A Truncated P2X7 Receptor Variant (P2X7-j) Endogenously Expressed in Cervical Cancer Cells Antagonizes the Full-length P2X7 Receptor through Hetero-oligomerization J. Biol. Chem., June 23, 2006; 281(25): 17228 - 17237. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. A. Weaver Epidemiology and Natural History of Genital Human Papillomavirus Infection J Am Osteopath Assoc, March 1, 2006; 106(suppl_1): S2 - S8. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Melnikow and S. Birch Human Papillomavirus Triage of Atypical Squamous Cells of Undetermined Significance: Cost-Effective, But At What Cost? J Natl Cancer Inst, January 18, 2006; 98(2): 82 - 83. [Full Text] [PDF]
|
|
|
|
|
|
S. L. Kulasingam, J. J. Kim, W. F. Lawrence, J. S. Mandelblatt, E. R. Myers, M. Schiffman, D. Solomon, and S. J. Goldie Cost-Effectiveness Analysis Based on the Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesion Triage Study (ALTS) J Natl Cancer Inst, January 18, 2006; 98(2): 92 - 100. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. F. Sawaya A 21-Year-Old Woman With Atypical Squamous Cells of Undetermined Significance JAMA, November 2, 2005; 294(17): 2210 - 2218. [Full Text] [PDF]
|
|
|
|
|
|
S. S. Wang, J. L. Walker, M. Schiffman, D. Solomon, and for the Atypical Squamous Cell of Undetermined Sig Evaluating the Risk of Cervical Precancer with a Combination of Cytologic, Virologic, and Visual Methods Cancer Epidemiol. Biomarkers Prev., November 1, 2005; 14(11): 2665 - 2668. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. P. Tabaei, W. H. Herman, A. F. Jabarin, and C. Kim Does Diabetes Care Compete With the Provision of Women's Preventive Care Services? Diabetes Care, November 1, 2005; 28(11): 2644 - 2649. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Lau and E. L. Franco Management of low-grade cervical lesions in young women Can. Med. Assoc. J., September 27, 2005; 173(7): 771 - 774. [Full Text] [PDF]
|
|
|
|
|
|
L. S. Massad, C. T. Evans, H. D. Strickler, R. D. Burk, D. H. Watts, L. Cashin, T. Darragh, S. Gange, Y.-C. Lee, M. Moxley, et al. Outcome After Negative Colposcopy Among Human Immunodeficiency Virus-Infected Women With Borderline Cytologic Abnormalities Obstet. Gynecol., September 1, 2005; 106(3): 525 - 532. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. R. Burstein, M. H. Snyder, D. Conley, D. R. Newman, C. M. Walsh, G. Tao, and K. L. Irwin Chlamydia Screening in a Health Plan Before and After a National Performance Measure Introduction Obstet. Gynecol., August 1, 2005; 106(2): 327 - 334. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. E. Castle, D. Solomon, M. Schiffman, C. M. Wheeler, and for the ALTS Group Human Papillomavirus Type 16 Infections and 2-Year Absolute Risk of Cervical Precancer in Women With Equivocal or Mild Cytologic Abnormalities J Natl Cancer Inst, July 20, 2005; 97(14): 1066 - 1071. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Khan, P. E. Castle, A. T. Lorincz, S. Wacholder, M. Sherman, D. R. Scott, B. B. Rush, A. G. Glass, and M. Schiffman The Elevated 10-Year Risk of Cervical Precancer and Cancer in Women With Human Papillomavirus (HPV) Type 16 or 18 and the Possible Utility of Type-Specific HPV Testing in Clinical Practice J Natl Cancer Inst, July 20, 2005; 97(14): 1072 - 1079. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Wright, R. M. Davila, K. R. Pinto, D. F. Merritt, R. K. Gibb, J. S. Rader, D. G. Mutch, F. Gao, and M. A. Powell Cervical Dysplasia in Adolescents Obstet. Gynecol., July 1, 2005; 106(1): 115 - 120. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Kim, T. C. Wright, and S. J. Goldie Cost-effectiveness of Human Papillomavirus DNA Testing in the United Kingdom, The Netherlands, France, and Italy J Natl Cancer Inst, June 15, 2005; 97(12): 888 - 895. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Coughlin, E. S. Breslau, T. Thompson, and V. B. Benard Physician Recommendation for Papanicolaou Testing Among U.S. Women, 2000 Cancer Epidemiol. Biomarkers Prev., May 1, 2005; 14(5): 1143 - 1148. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Boardman, C. Stanko, S. Weitzen, and C. J. Sung Atypical Squamous Cells of Undetermined Significance: Human Papillomavirus Testing in Adolescents Obstet. Gynecol., April 1, 2005; 105(4): 741 - 746. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Temam, J. Benard, C. Dugas, M. Trassard, E. Gormally, J.-C. Soria, S. Faivre, B. Luboinski, P. Marandas, P. Hainaut, et al. Molecular Detection of Early-Stage Laryngopharyngeal Squamous Cell Carcinomas Clin. Cancer Res., April 1, 2005; 11(7): 2547 - 2551. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Schiffman, M. J. Khan, D. Solomon, R. Herrero, S. Wacholder, A. Hildesheim, A. C. Rodriguez, M. C. Bratti, C. M. Wheeler, R. D. Burk, et al. A Study of the Impact of Adding HPV Types to Cervical Cancer Screening and Triage Tests J Natl Cancer Inst, January 19, 2005; 97(2): 147 - 150. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. W. Brawley and B. S. Kramer Cancer Screening in Theory and in Practice J. Clin. Oncol., January 10, 2005; 23(2): 293 - 300. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Smith, V. Cokkinides, and H. J. Eyre American Cancer Society Guidelines for the Early Detection of Cancer, 2005 CA Cancer J Clin, January 1, 2005; 55(1): 31 - 44. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Saraiya and G. F. Sawaya Cervical Cancer Screening Among Women Without a Cervix JAMA, October 6, 2004; 292(13): 1551 - 1551. [Full Text] [PDF]
|
|
|
|
|
|
B. Sirovich and H. G. Welch Cervical Cancer Screening Among Women Without a Cervix--Reply JAMA, October 6, 2004; 292(13): 1551 - 1552. [Full Text] [PDF]
|
|
|
|
 |
|
 D. R. Blake, B. M. Weber, and K. E. Fletcher Adolescent and Young Adult Women's Misunderstanding of the Term Pap Smear Arch Pediatr Adolesc Med, October 1, 2004; 158(10): 966 - 970. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Anhang, A. Goodman, and S. J. Goldie HPV Communication: Review of Existing Research and Recommendations for Patient Education CA Cancer J Clin, September 1, 2004; 54(5): 248 - 259. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Eyre, R. Kahn, R. M. Robertson, and and the ACS/ADA/AHA Collaborative Writing Committe Preventing Cancer, Cardiovascular Disease, and Diabetes: A Common Agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association Stroke, August 1, 2004; 35(8): 1999 - 2010. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Eyre, R. Kahn, R. M. Robertson, and the ACS/ADA/AHA Collaborative Writing Committe, N. G. Clark, C. Doyle, T. Gansler, T. Glynn, Y. Hong, R. A. Smith, et al. Preventing Cancer, Cardiovascular Disease, and Diabetes: A Common Agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association CA Cancer J Clin, July 1, 2004; 54(4): 190 - 207. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Eyre, R. Kahn, and R. M. Robertson Preventing Cancer, Cardiovascular Disease, and Diabetes: A common agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association Diabetes Care, July 1, 2004; 27(7): 1812 - 1824. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Eyre, R. Kahn, R. M. Robertson, the ACS/ADA/AHA Collaborative Writing Committee, ACS/ADA/AHA Collaborative Writing Committee Member, N. G. Clark, C. Doyle, Y. Hong, T. Gansler, T. Glynn, et al. Preventing Cancer, Cardiovascular Disease, and Diabetes: A Common Agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association Circulation, June 29, 2004; 109(25): 3244 - 3255. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. E. Sirovich and H. G. Welch Cervical Cancer Screening Among Women Without a Cervix JAMA, June 23, 2004; 291(24): 2990 - 2993. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Kahn Self-testing for human papillomavirus using a vaginal swab: placing prevention of cervical cancer in the patient's hands Ann. Onc., June 1, 2004; 15(6): 847 - 849. [Full Text] [PDF]
|
|
|
|
|
|
L. C. Walter, K. Lindquist, and K. E. Covinsky Relationship between Health Status and Use of Screening Mammography and Papanicolaou Smears among Women Older Than 70 Years of Age Ann Intern Med, May 4, 2004; 140(9): 681 - 688. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Goldie, M. Kohli, D. Grima, M. C. Weinstein, T. C. Wright, F. X. Bosch, and E. Franco Projected Clinical Benefits and Cost-effectiveness of a Human Papillomavirus 16/18 Vaccine J Natl Cancer Inst, April 21, 2004; 96(8): 604 - 615. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. M. Taylor, Y. Yasui, N. Burke, T. Nguyen, E. Acorda, H. Thai, P. Qu, and J. C. Jackson Pap Testing Adherence among Vietnamese American Women Cancer Epidemiol. Biomarkers Prev., April 1, 2004; 13(4): 613 - 619. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Zahn Human Papillomavirus DNA Testing as an Adjunct in Primary Screening: Is It Prime Time? Obstet. Gynecol., April 1, 2004; 103(4): 617 - 618. [Full Text] [PDF]
|
|
|
|
|
|
S. J. Goldie, J. J. Kim, and T. C. Wright Cost-Effectiveness of Human Papillomavirus DNA Testing for Cervical Cancer Screening in Women Aged 30 Years or More Obstet. Gynecol., April 1, 2004; 103(4): 619 - 631. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Wright, A. B. Pinto, M. A. Powell, D. W. Lu, F. Gao, and K. R. Pinto Atypical Squamous Cells of Undetermined Significance in Girls and Women Obstet. Gynecol., April 1, 2004; 103(4): 632 - 638. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. F. Sawaya Should Routine Screening Papanicolaou Smears Be Done for Women Older Than 65 Years? Arch Intern Med, February 9, 2004; 164(3): 243 - 245. [Full Text] [PDF]
|
|
|
|
|
|
J. Mandelblatt, W. Lawrence, B. Yi, and J. King The Balance of Harms, Benefits, and Costs of Screening for Cervical Cancer in Older Women: The Case for Continued Screening Arch Intern Med, February 9, 2004; 164(3): 245 - 247. [Full Text] [PDF]
|
|
|
|
|
|
T. C. Wright Jr, M. Schiffman, D. Solomon, J. T. Cox, F. Garcia, S. Goldie, K. Hatch, K. L. Noller, N. Roach, C. Runowicz, et al. Interim Guidance for the Use of Human Papillomavirus DNA Testing as an Adjunct to Cervical Cytology for Screening Obstet. Gynecol., February 1, 2004; 103(2): 304 - 309. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-P. Lin, Y.-Y. Huang, H.-Y. Wu, and J.-T. Kao Method for Testing for Human Papillomavirus Infection in Patients with Cervical Intraepithelial Disease J. Clin. Microbiol., January 1, 2004; 42(1): 366 - 368. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Smith, V. Cokkinides, and H. J. Eyre American Cancer Society Guidelines for the Early Detection of Cancer, 2004 CA Cancer J Clin, January 1, 2004; 54(1): 41 - 52. [Abstract] [Full Text] [PDF]
|
|
|
